Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences Statistics

Total Valuation

INBX has a market cap or net worth of $1.26 billion. The enterprise value is $1.23 billion.

Market Cap	1.26B
Enterprise Value	1.23B

Important Dates

The last earnings date was Friday, November 14, 2025, before market open.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

INBX has 14.54 million shares outstanding. The number of shares has increased by 6.72% in one year.

Current Share Class	14.54M
Shares Outstanding	14.54M
Shares Change (YoY)	+6.72%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	18.93%
Owned by Institutions (%)	43.32%
Float	7.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	908.05
Forward PS	n/a
PB Ratio	34.41
P/TBV Ratio	34.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	875.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.49, with a Debt / Equity ratio of 2.90.

Current Ratio	4.49
Quick Ratio	4.28
Debt / Equity	2.90
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-21.65

Financial Efficiency

Return on equity (ROE) is -144.07% and return on invested capital (ROIC) is -75.27%.

Return on Equity (ROE)	-144.07%
Return on Assets (ROA)	-60.97%
Return on Invested Capital (ROIC)	-75.27%
Return on Capital Employed (ROCE)	-137.91%
Revenue Per Employee	$8,696
Profits Per Employee	-$963,267
Employee Count	161
Asset Turnover	0.01
Inventory Turnover	55.38

Taxes

In the past 12 months, INBX has paid $2,000 in taxes.

Income Tax	2,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +475.67% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+475.67%
50-Day Moving Average	59.96
200-Day Moving Average	28.13
Relative Strength Index (RSI)	69.22
Average Volume (20 Days)	275,138

Short Selling Information

The latest short interest is 1.14 million, so 7.81% of the outstanding shares have been sold short.

Short Interest	1.14M
Short Previous Month	1.03M
Short % of Shares Out	7.81%
Short % of Float	14.44%
Short Ratio (days to cover)	6.46

Income Statement

In the last 12 months, INBX had revenue of $1.40 million and -$155.09 million in losses. Loss per share was -$10.03.

Revenue	1.40M
Gross Profit	-145.55M
Operating Income	-195.13M
Pretax Income	-155.08M
Net Income	-155.09M
EBITDA	-192.52M
EBIT	-195.13M
Loss Per Share	-$10.03

Balance Sheet

The company has $153.09 million in cash and $106.91 million in debt, giving a net cash position of $46.18 million or $3.18 per share.

Cash & Cash Equivalents	153.09M
Total Debt	106.91M
Net Cash	46.18M
Net Cash Per Share	$3.18
Equity (Book Value)	36.83M
Book Value Per Share	2.54
Working Capital	125.44M

Cash Flow

In the last 12 months, operating cash flow was -$143.39 million and capital expenditures -$47,000, giving a free cash flow of -$143.44 million.

Operating Cash Flow	-143.39M
Capital Expenditures	-47,000
Free Cash Flow	-143.44M
FCF Per Share	-$9.86

Margins

Gross Margin	n/a
Operating Margin	-13,937.86%
Pretax Margin	-11,077.43%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

INBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.72%
Shareholder Yield	-6.72%
Earnings Yield	-12.20%
FCF Yield	-11.28%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-51.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

INBX has an Altman Z-Score of -3.43 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.43
Piotroski F-Score	2